These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 23401677)

  • 21. Extraesophageal manifestations of GERD.
    Napierkowski J; Wong RK
    Am J Med Sci; 2003 Nov; 326(5):285-99. PubMed ID: 14615670
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mean Nocturnal Baseline Impedance Correlates With Symptom Outcome When Acid Exposure Time Is Inconclusive on Esophageal Reflux Monitoring.
    Rengarajan A; Savarino E; Della Coletta M; Ghisa M; Patel A; Gyawali CP
    Clin Gastroenterol Hepatol; 2020 Mar; 18(3):589-595. PubMed ID: 31163276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Facts and Fantasies on Extraesophageal Reflux: A Gastroenterologist Perspective.
    Zerbib F; Dulery C
    J Clin Gastroenterol; 2017 Oct; 51(9):769-776. PubMed ID: 28858946
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of extraesophageal reflux in patients with symptoms of gastroesophageal reflux.
    Ylitalo R; Ramel S; Hammarlund B; Lindgren E
    Otolaryngol Head Neck Surg; 2004 Jul; 131(1):29-33. PubMed ID: 15243554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Symptoms, quality of life, videolaryngoscopy, and twenty-four-hour triple-probe pH monitoring in patients with typical and extraesophageal reflux.
    Powitzky ES; Khaitan L; Garrett CG; Richards WO; Courey M
    Ann Otol Rhinol Laryngol; 2003 Oct; 112(10):859-65. PubMed ID: 14587976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relationship between extralaryngeal endoscopic findings, proton pump inhibitor (PPI) response, and pH measures in suspected laryngopharyngeal reflux.
    Agrawal N; Yadlapati R; Shabeeb N; Price CP; Lidder A; Shintani-Smith S; Bové M; Pandolfino J; Tan B
    Dis Esophagus; 2019 Apr; 32(4):. PubMed ID: 30101358
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of impedance monitoring in patients with extraesophageal symptoms.
    Kavitt RT; Yuksel ES; Slaughter JC; Garrett CG; Hagaman D; Higginbotham T; Vaezi MF
    Laryngoscope; 2013 Oct; 123(10):2463-8. PubMed ID: 23857711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily.
    Gasiorowska A; Navarro-Rodriguez T; Wendel C; Krupinski E; Perry ZH; Koenig K; Moty B; Powers J; Fass R
    Am J Gastroenterol; 2009 Aug; 104(8):2005-13. PubMed ID: 19491829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical utility of salivary pepsin measurement in patients with proton pump inhibitor-refractory gastroesophageal reflux disease symptoms: a prospective comparative study.
    Matsumura T; Arai M; Suzuki T; Hoppo T; Seki Y; Kasamatsu S; Ishigami H; Ishikawa K; Okimoto K; Akizue N; Maruoka D; Nakagawa T; Odaka T; Okamoto Y; Kato N
    Esophagus; 2020 Jul; 17(3):339-347. PubMed ID: 31982992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Abnormal GERD parameters on ambulatory pH monitoring predict therapeutic success in noncardiac chest pain.
    Kushnir VM; Sayuk GS; Gyawali CP
    Am J Gastroenterol; 2010 May; 105(5):1032-8. PubMed ID: 19920808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oropharyngeal pH Testing Does Not Predict Response to Proton Pump Inhibitor Therapy in Patients with Laryngeal Symptoms.
    Yadlapati R; Pandolfino JE; Lidder AK; Shabeeb N; Jaiyeola DM; Adkins C; Agrawal N; Cooper A; Price CP; Ciolino JD; Gawron AJ; Smith SS; Bove M; Tan BK
    Am J Gastroenterol; 2016 Nov; 111(11):1517-1524. PubMed ID: 27091320
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Usefulness of baseline impedance in patients with proton pump inhibitor-refractory nonerosive reflux disease.
    Kohata Y; Fujiwara Y; Yamagami H; Tanigawa T; Shiba M; Watanabe K; Watanabe T; Tominaga K; Arakawa T
    J Gastroenterol Hepatol; 2015 Mar; 30 Suppl 1():36-40. PubMed ID: 25827802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic rhinosinusitis and extraesophageal reflux: Who is the candidate for antireflux treatment?
    Zeleník K; Formánek M; Matoušek P; Komínek P
    Am J Rhinol Allergy; 2016; 30(2):e5-9. PubMed ID: 26980378
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of proton pump inhibitor-resistant nonerosive reflux disease by esophageal manometry and 24-hour esophageal impedance and pH monitoring.
    Kawamura O; Hosaka H; Shimoyama Y; Kawada A; Kuribayashi S; Kusano M; Yamada M
    Digestion; 2015; 91(1):19-25. PubMed ID: 25632912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of improvement of impaired chemical clearance characterizes PPI-refractory reflux-related heartburn.
    Frazzoni M; Frazzoni L; Tolone S; De Bortoli N; Savarino V; Savarino E
    Am J Gastroenterol; 2018 May; 113(5):670-676. PubMed ID: 29681623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of the Gastroesophageal Reflux Disease Questionnaire (GerdQ) in predicting the proton pump inhibitor response in coronary artery disease patients with gastroesophageal reflux-related chest pain.
    He S; Liu Y; Chen Y; Tang Y; Xu J; Tang C
    Dis Esophagus; 2016 May; 29(4):367-76. PubMed ID: 25721424
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association Between Inferior Turbinate Hypertrophy and Extraesophageal Reflux.
    Zeleník K; Javorská Z; Taimrová R; Vrtková A; Hránková V; Tedla M; Lukácová K; Lubojacký J; Formánek M; Komínek P
    JAMA Otolaryngol Head Neck Surg; 2022 Aug; 148(8):773-778. PubMed ID: 35771544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Value of pH probe testing in pediatric patients with extraesophageal manifestations of gastroesophageal reflux disease: a retrospective review.
    Bauman NM; Bishop WP; Sandler AD; Smith RJ
    Ann Otol Rhinol Laryngol Suppl; 2000 Oct; 184():18-24. PubMed ID: 11051426
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extraesophageal Symptoms and Diseases Attributed to GERD: Where is the Pendulum Swinging Now?
    Vaezi MF; Katzka D; Zerbib F
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1018-1029. PubMed ID: 29427733
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.